Hemolytic anemia resident survival guide: Difference between revisions

Jump to navigation Jump to search
Line 35: Line 35:
* [[Thrombotic thrombocytopenic purpura]]
* [[Thrombotic thrombocytopenic purpura]]
* [[Hemolytic uremic syndrome]]
* [[Hemolytic uremic syndrome]]
* [[Pre eclampsia]] and [[malignant hypertension]]
* [[Pre-eclampsia]] and [[malignant hypertension]]


'''Other causes'''
'''Other causes'''

Revision as of 15:48, 30 July 2020

Hemolytic anemia
Resident Survival Guide
Overview
Causes
FIRE
Diagnosis
Treatment
Do's
Don'ts


Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];

Overview

Causes

Life threatening causes

Other causes

For a complete list of hemolytic anemia causes click here

FIRE

Diagnosis

Treatment

Do's

Don'ts

References

  1. Phillips J, Henderson AC (2018). "Hemolytic Anemia: Evaluation and Differential Diagnosis". Am Fam Physician. 98 (6): 354–361. PMID 30215915.
  2. Renard D, Rosselet A (2017). "Drug-induced hemolytic anemia: Pharmacological aspects". Transfus Clin Biol. 24 (3): 110–114. doi:10.1016/j.tracli.2017.05.013. PMID 28648734.
  3. Morishita E (2015). "[Diagnosis and treatment of microangiopathic hemolytic anemia]". Rinsho Ketsueki. 56 (7): 795–806. doi:10.11406/rinketsu.56.795. PMID 26251142.
  4. Barcellini W, Bianchi P, Fermo E, Imperiali FG, Marcello AP, Vercellati C; et al. (2011). "Hereditary red cell membrane defects: diagnostic and clinical aspects". Blood Transfus. 9 (3): 274–7. doi:10.2450/2011.0086-10. PMC 3136593. PMID 21251470.